(Q43876123)

English

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

scientific article published on 19 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

tenofovir/emtricitabine

1 reference

based on heuristic

inferred from title

atazanavir/ritonavir

1 reference

based on heuristic

inferred from title

0 references

Pierluigi Viale

9

object named as

Pierluigi Viale

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Filippo Trapani

2

object named as

Filippo Trapani

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Leonardo Calza

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Caterina Salvadori

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Eleonora Magistrelli

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Roberto Manfredi

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Vincenzo Colangeli

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Maria Assunta Di Bari

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Marco Borderi

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

19 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Scandinavian Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

147-154

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

The nephrotoxic effects of HAART.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Subcellular renal proximal tubular mitochondrial toxicity with tenofovir treatment

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Long-term renal safety of tenofovir disoproxil fumarate in vertically HIV-infected children, adolescents and young adults: a 60-month follow-up study.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Association of tenofovir exposure with kidney disease risk in HIV infection

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Low incidence of renal impairment observed in tenofovir-treated patients.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Determination of Kidney Function Before Tenofovir Initiation: Four-Fold Difference in Need of Tenofovir Dose Reduction Depending on Method Used

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Tenofovir renal safety in HIV-infected patients: Results from the SCOLTA Project

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

No change in calculated creatinine clearance after tenofovir initiation among Thai patients

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2012.712213

21 January 2018

Identifiers

10.3109/00365548.2012.712213

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43876123&oldid=2104082163"